Selected Science Publications
Research Papers
1) Shanahan F, Brogan M, Nayersina R, Targan S. Cytotoxic lymphocytes in human intestinal mucosa.
Adv Exp Med Biol. 216A:457-63, 1987.
https://pubmed.ncbi.nlm.nih.gov/3500580/
2) Shanahan F, Deem R, Nayersina R, Leman B, Targan S. Human mucosal T-cell cytotoxicity. Gastroenterology 94: 960-7, 1988.
https://pubmed.ncbi.nlm.nih.gov/2450050/
3) McBride W.H, Economou J.S, Nayersina R, Comora S, Essner R. Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes. Cancer Research 50: 2949-52, 1990.
https://pubmed.ncbi.nlm.nih.gov/2334896/
4) Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlict H.J, Vitiello A, Chesnut R, Person J.L, Redeker A.G, Chisari F.V. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Journal of Immunology 150: 4659-71, 1993.
https://pubmed.ncbi.nlm.nih.gov/7683326/
5) Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast W.M, Melief C.J.M, Oseroff C, Yuan L, Ruppert J, Sidney J, Del Guercio M.F, Southwood S, Kubo R.T, Chestnut R.W, Grey H.M, Chisari F.V. The relationship between class I binding affinity and immunogenecity of potential cytotoxic T cell epitopes. Journal of Immunology 153: 5586-92, 1994.
https://pubmed.ncbi.nlm.nih.gov/7527444/
Book Chapters
1) Shanhan F, Brogan M, Nayersina R, Targan S. “Cytotoxic lymphocytes in human intestinal mucosa”. In: Recent advances in mucosal immunology. Eds. Mestecky J, McGhee J.R, Bienenstock J, Ogra P.L, Plenum press; 457-63, 1987.
2) Fowler P, Nayersina R, Missale G, Bertoletti A, Penna A, Ando K, Cerny A, Fiaccadori F, Ferrari C, Chisari F.V. “The Role of the Cytotoxic T lymphocyte Response in Hepatitis B virus immunobiology and pathogenesis”. In: Viral Hepatitis and Liver Disease. Eds. Nishioka k, Suzuki H, Mishiro S, Oda T, Springer-Verlag; 173-177, 1994.
Abstracts
1) Shanahan F, Brogan M, Dang J, Nayersina R, Targan S. Neuropeptide stimulation of the respiratory burst by human phagocytic cells. FASEB meeting, St. Louis Mo. April 1986.Fed. Proc. 45; 635, 1986.
2) Shanahan F, Brogan M, Nayersina R, Targan S. Spontaneous and lymphokine activated killer cells exist in the human intestine as phenotypically distinct subpopulations.AGA meeting, San Francisco, California, May 1986. Gastroenterology 90; 1629,1986.
3) Shanahan F, Brogan M, Nayersina R, Targan S. Cytotoxic Lymphocytes in human intestinal mucosa. International Congress of Mucosal Immunology, Niagara Falls,New York, 1986.
4) Brogan M, Shanahan F, Nayersina R, Targan S. Immunoglobulin producing cells isolated from human intestine are responsive to help from autologous mucosal T cells. Gastroenterology 90;1358,1986.
5) Shanahan F, Deem R, Nayersina R, Niederlehner A, Leman B, Targan S. Mucosal T cell cytotoxicity triggered by anti-CD3 antibodies. Gastroenterology 92;1635,1987.
6) Leman B, Shanahan F, Deem R, Brogan M, Niederlehner A, Nayersina R, Targan S. Enhanced non-MHC-restricted peripheral blood T cell cytotoxicity in inflammatory bowel disease. Gastroenterology 92;1499,1987.
7) Nayersina R, Cohen M, McBride W.H. Soluble and non-soluble anti-CD3 antibody activate T cells in vitro and stimulate anti-tumor immunity in vivo. FASEB meeting, Atlanta GA, 1991. FASEB Journal 5:(5) Part III A1713 1991.
8) Nayersina R, Missale G, Fowler P, Bertoletti A, Penna A, Ferrari C, Chisari F.V. Cytotoxic T cell responses specific for envelope and core epitopes of hepatitis B virus in patients with acute viral hepatitis type B. FASEB meeting, Anaheim CA, 1992. FASEB Journal 6:(4) Part I A1071 1992.
9) Missale G, Ferrari C, Penna A, Bertoletti A, Fiaccadori F, Fowler P, Nayersina R, Guilhot S, Chisari F.V. Cytotoxic T cell response to hepatitis B virus core and envelope antigens in viral hepatitis. 8th International Congress of Immunology, Budapest, Hungary 1992.
10) Missale G, Fowler P, Nayersina R, Bertoletti A, Penna A, Redeker A, Person J, Pockros P, Chesnut B, Vitiello A, Fiaccadori F, Ferrari C, Chisari F. Epitope mapping of the cytotoxic T cell response to hepatitis B virus core and envelope antigens in patients with acute viral hepatitis. 1992 Molecular Biology of Hepatitis B Virus. University of California, San Diego. Aug 30-Sep 3 1992.
11) Vitiello A, Furze J, Farness P, Arrhenius T, Maewal A, Colon S, Gaeta F, Ferrari C, Missale G, Fowler P, Nayersina R, Chisari F.V, Chesnut R. Enhancement of peptide immunogenicity for CTL induction by linkage to a T helper peptide. 1992 Molecular Biology of Hepatitis B Virus. University of California, San Diego. Aug 30-Sep 3 1992.
12) Vitiello A, Farness P, Furze J, Arrhenius T, Maewal A, Colon S, Gaeta F, Ferrari C, Missale G, Fowler P, Nayersina R, Chisari F.V, Chesnut R. Definition of optimal HBV core and envelope CTL epitopes using A2.1 transgenic mouse CTL. 1992 Molecular Biology of Hepatitis B Virus. University of California, San Diego. Aug 30-Sep 3 1992.
13) Chisari F.V, Fowler P, Nayersina R, Cerny A, Rehermann B, Schlicht H.J, Missale G, Bertoletti A, Ferrari C. The HLA class I restricted cytotoxic T lymnphocyte response to the hepatitis B virus. Synmposium on Viral Hepatitis and Liver Disease, Tokyo Japan 1993.
14) Chisari F.V, Fowler P, Nayersina R, Cerny A, Missale G, Ferrari C. The HLA class I restricted Cytotoxic T lymphocyte response to the Hepatitis-B Virus. Journal of Cellular Biochemistry Iss S17D: 37 1993.
15) Chisari F.V, Fowler P, Nayersina R, Cerny A, Missale G, Ferrari C. The HLA class I restricted Cytotoxic T lymphocyte response to the Hepatitis-B Virus. 1993 Molecular Biology of Hepatitis B Virus. Georgetown University, Washington D.C. Aug 1-6 1993.
